Web Results


Feb 15, 2018 ... BELL v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al, No. 2: 2017cv01153 - Document 20 (W.D. Pa. 2018) case opinion from ...


Machala v. Boehringer Ingelheim Pharmaceuticals, Inc., et al.


... INC. et al v. HEC PHARM CO., LTD. et al, case number 3:15-cv-05982, from New Jersey Court. ... BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. ...... GREGORY D. MILLER, RIVKIN RADLER LLP TERMINATED: 03/16/ 2016.


Parties, docket activity and news coverage of federal case AbbVie Inc. et al v. Boehringer Ingelheim International GMBH et al, case number 1:17-cv-01065, from Delaware Court. ... Counter Claimant. Boehringer Ingelheim Pharmaceuticals, Inc.


Aug 21, 2017 ... Federal Trade Commission v. Boehringer Ingelheim Pharmaceuticals, Inc. (D.C. Cir.), Final Opening Brief of the Federal Trade Commission, ...


Jan 5, 2017 ... 15-5982 - BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al.


See the complete profile on LinkedIn and discover Edward's connections and ... Alexion Pharmaceuticals, Inc.,; Boehringer Ingelheim,; U.S. Department of Justice ... that met/exceeded all statutory and life sciences industry requirements at two ... Owner & CEO WGOJ E.T.'s Gospel of Jazz Radio Show Internet Radio Station.


Boehringer Ingelheim Pharmaceuticals, Inc. et al ... 3:18-cv-00121-JHM-CHL Servpro Intellectual Property, Inc. et al v. ... 3:16-cv-00621-DJH-DW Miller v.


patients with EGFR mutation-positive non-small-cell lung cancer and acquired ... h Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, ...... [18] V.A. Miller, V. Hirsh, J. Cadranel, et al., Afatinib versus placebo for patients with.